Navigation Links
Heparin Antibodies May Put Patients At Risk

Patients developing antibodies to heparin, an anti-clotting drug, run the risk of either serious complications after undergoing a heart surgery, or death, according to a new research // . The Wake Forest University Baptist Medical Center’s professor of anesthesiology Thomas Slaughter said that the study aimed at finding out if an independent risk is posed by the development of heparin antibodies prior to the surgery.

Heparin is used in several procedures like heart catheterization or angioplasty, kidney dialysis, in addition to heart and vascular surgeries. Antibodies are developed in as many as 50% of the patients who are treated with heparin, the effect of which may even last for several months. The researchers are of the opinion that blood components are activated which cause inflammation and clotting in the case of subsequent treatment on patients who already carry heparin antibodies.

This will also lead to increased risks of strokes, heart rhythm problems, heart attacks, and other complications. The heparin antibody levels in the patients were studied by the researchers, before surgery, who came to the conclusion that the risk of hospitalization or death was twofold in the case of patients with the antibodies.

The Parsonnet risk score, a standardized risk scoring system was also used by the research scientists to ensure that the results of the study were not influenced by the baseline health status of the patients. The heparin antibodies were found in 13% of the patients who were to undergo surgery in the US.

Heparin can be easily be replaced by many other anti-clotting medications, but the Food and Drug Administration of the country will have to approve of them before they can be used. Patients may also postpone the surgery until the antibody levels in their bodies have subsided, which may at times take months together, and may not be practical if the patient concerned requires surgery immediately.


'"/>




Page: 1

Related medicine news :

1. Complications In Kidney Failure Patients Linked To Heparin
2. Heparin does not protect from recurrent heart attacks
3. Heparin Based Nanoscale Materials Developed For Dialysis Treatment
4. Ordinary Heparin as Effective as Expensive Blood Thinner
5. Antibodies to fight HIV infection.
6. Survival of Mice With Human Breast Cancer Extended by Monoclonal Antibodies
7. Scientists Develop Antibodies from Plant Seeds
8. Antibodies in Mother Affect Heart of Fetus
9. One in Three Heart Attack Patients Have No Chest Pains
10. Amphetamines Help Recovery of Stroke Patients
11. Painkillers Do Not Shorten Dying Patients Lives
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Heparin Antibodies May Put Patients Risk

(Date:7/30/2014)... July 30, 2014 Hospitals continually ... quality of care that their practitioners provide. During ... Andrew Rowe, discussed the importance of establishing effective ... physician performance and quality of care. , ... evaluation, Mr. Rowe elaborated on setting performance expectations, ...
(Date:7/30/2014)... Frozen shoulder (Adhesive capsulitis) affects 10-20 percent ... this nasty condition which occurs most frequently in people between ... to two and half years if not treated. , Adhesive ... good reason: it can render your shoulder so stiff, it's ... you aren't in too much pain to get dressed in ...
(Date:7/30/2014)... (HealthDay News) --,Although the vast majority of kids with ... wired very differently from children who have trouble processing ... disorders (SPD) can be overly sensitive to sound, sight ... and show a lack of concentration. Complicating matters, ... others. Some have trouble tolerating loud noises, like a ...
(Date:7/30/2014)... India (PRWEB) July 30, 2014 On ... Campaign, and the Indian Institute of Public Health, Gandhinagar ... Microfinance in India, Volume II: The Way Forward .” ... Asia Conference on Policies and Practices to Improve Nutrition ... the "Indian Father of the Green Revolution" and chair ...
(Date:7/30/2014)... 2014 The North America aviation actuator ... 2019. North America is expected to be the fastest ... a CAGR of 5.60%. , The commercial aircraft ... which will assume prominence in the years to come. ... the sector has regained quickly, and the industry has ...
Breaking Medicine News(10 mins):Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4Health News:Different Areas of Brain Affected in Autism, Sensory Disorders 2Health News:Different Areas of Brain Affected in Autism, Sensory Disorders 3Health News:New Report on Integrated Health and Microfinance in India Shows the Way Forward 2Health News:New Report on Integrated Health and Microfinance in India Shows the Way Forward 3Health News:New Report on Integrated Health and Microfinance in India Shows the Way Forward 4Health News:North America Aviation Actuation System Market is Expected to Reach $1781.02 million in 2019 - New Report by MicroMarket Monitor 2Health News:North America Aviation Actuation System Market is Expected to Reach $1781.02 million in 2019 - New Report by MicroMarket Monitor 3Health News:North America Aviation Actuation System Market is Expected to Reach $1781.02 million in 2019 - New Report by MicroMarket Monitor 4
... of the effects of regulation on small businesses ... entrepreneurship, according to a new RAND Corporation report. ... Policy report provides an overview of the ways ... or encourage the entrepreneurial spirit. It also ...
... Biodel Inc. (Nasdaq:,BIOD) today reported fourth quarter and ... pipeline progress and disclosed 2008,objectives., "In 2007, ... advanced our pipeline,and achieved critical corporate objectives," stated ... significant milestones reached include our,successful initial public offering, ...
... Calif., Dec. 11 Varian Medical,Systems (NYSE: VAR ... the company,s Annual Meeting of Stockholders for February 14,2008 ... meeting will be held at,the Sheraton Palo Alto, 625 ... The meeting will be webcast by CCBN and ...
... such as lumps, the ability of diagnostic mammograms to ... reads them, according to a Group Health study published ... National Cancer Institute., When a woman gets a mammogram, ... cancer, the mammogram will be likely to detect it, ...
... Simple bystander-delivered CPR without mouth-to-mouth boosted survival outcomes ... compressions alone (without mouth-to-mouth resuscitation) may be as ... mouth-to-mouth) when bystanders come to the aid of ... conclusion of two studies published in the Dec. ...
... be needed, experts say , , TUESDAY, Dec. 11 (HealthDay ... care for low-income seniors produced mixed results, a geriatrics ... the need for a new analysis of how Medicare ... , "We were able to stabilize medical care for ...
Cached Medicine News:Health News:Rand study examines the effect of policy on entrepreneurship and small businesses 2Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 2Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 3Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 4Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 5Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 6Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 7Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 8Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 9Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Accuracy of diagnostic mammograms varies by radiologist 2Health News:Chest Compressions Effective in Emergency Cardiac Arrest 2Health News:Home-Based Senior Care Program Has Limited Benefits 2
(Date:7/30/2014)... -- Stryker brand ambassadors Fred Funk and Hal ... Tour event near Minneapolis, MN , which begins ... Stryker is the official joint replacement products company of the PGA ... st through Sunday, August 3 rd , fans will be ... destination located in the Pioneer Press Expo tent located near the ...
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... and SAN DIEGO , July ... ARNA ) announced today that an article based ... of lorcaserin entitled, "Early Weight Loss While on Lorcaserin, Diet, ... was recently published in the online issue of Obesity ... The objective of these analyses was to identify whether there ...
Breaking Medicine Technology:Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7
... Mylan Inc. (Nasdaq: MYL ) today announced that it has ... amount of 7.625% Senior Notes due 2017 and $700 million ... is using $1.0 billion of the net proceeds from ... loans, thereby reducing senior secured leverage and extending the maturity profile ...
... SHENZHEN, China , May 19 /PRNewswire-Asia/ ... Medical" or the "Company"), a leading manufacturer of,medical dressings, ... consumer products industries, announced today that in,connection with the ... common stock, par value $0.001 per share, ...
Cached Medicine Technology:Mylan Announces Completion of Senior Notes Offering 2Winner Medical Group Inc. Announces Exercise of Over-Allotment Option Bringing Aggregate Net Proceeds of the Public Offering to $8.8 Million 2Winner Medical Group Inc. Announces Exercise of Over-Allotment Option Bringing Aggregate Net Proceeds of the Public Offering to $8.8 Million 3Winner Medical Group Inc. Announces Exercise of Over-Allotment Option Bringing Aggregate Net Proceeds of the Public Offering to $8.8 Million 4
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... Spica Splint provides effective long-term stabilization ... fit. Adjustable radial and palmar stays ... Gamekeper's thumb, de Quervain's, scaphoid and ... straps.,FormFit™ Splints offer superior fit and ...
Qualcare™ Thumb Spica...
... QuickCast® Cast-like splints Slip ... dryer, and QuickCast conforms to ... cools. Reheat to adjust and ... coated with a temperature-sensitive polymer ...
Medicine Products: